Related Experiment Video
Updated: Jun 6, 2025

Assessing Iron Deposition in the Brains of 5xFAD Mice by Perls'/DAB Staining
Published on: May 23, 2025
[Research progress of metalloporphyrin against neurodegene-rative diseases]
Jie Chen1, Jing Lu2, Qingyi Wang3
1College of Pharmaceutical Science, Zhejiang University of Technology, Hangzhou 310014, China. 221122070256@zjut.edu.cn.
Abstract:
Neurodegenerative diseases are a group of diseases caused by the degeneration and apoptosis of neurons in the brain and spinal cord, which seriously affect human ability of motion perception, memory and cognition. Peroxynitrite can cause oxidative damage in the brain by exhibiting neurotoxicity, and its excessive accumulation is closely related to neurodegenerative diseases. Therefore, effectively scavenging peroxynitrite may become a therapeutic strategy for neurodegenerative diseases. Due to their high peroxynitrite scavenging ability, water-soluble metalloporphyrins have recently attracted much attention. Metalloporphyrins such as iron porphyrins and manganese porphyrins have neuroprotective effects, including inhibiting amyloid plaque accumulation, alleviating oxidative stress and neuroinflammatory damage, improving mitochondrial function and reducing neuronal apoptosis. However, some metalloporphyrins have poor blood-brain barrier penetration. To overcome this obstacle, in addition to traditional synthesis processes, metalloporphyrins can also be prepared into nanoparticles to improve bioavailability in vivo. Here, we will review the mechanisms underlying the neuroprotective effects of metalloporphyrins and explore their therapeutic potential for neurodegenerative diseases.

